| Gene Symbol | Pearson Correlation Coefficient |
|---|---|
| HBA2 | 0.868 |
| HBB | 0.839 |
| ALAS2 | 0.777 |
| HBD | 0.731 |
| SLC4A1 | 0.607 |
| CST7 | 0.566 |
| AHSP | 0.555 |
| FCN1 | 0.554 |
| S100A9 | 0.55 |
| CA1 | 0.549 |
| Gene Symbol | Pearson Correlation Coefficient |
|---|---|
| GLRA3 | -0.456 |
| ZNF804A | -0.443 |
| CBLN4 | -0.437 |
| CNR1 | -0.435 |
| VSTM2A | -0.431 |
| RTP1 | -0.428 |
| NDST3 | -0.428 |
| HAS1 | -0.427 |
| KCNG1 | -0.426 |
| C3orf80 | -0.425 |
| ID | Drug Name | Drug Type | CAS Num | Status | Role |
|---|---|---|---|---|---|
| DB00358 | Mefloquine | Small Molecule | 53230-10-7 | Approved|Investigational | Target |
| DB00893 | Iron Dextran | Small Molecule | 9004-66-4 | Approved | Target |
| DB01592 | Iron | Small Molecule | 7439-89-6 | Approved | Target |
| DB01593 | Zinc | Small Molecule | 7440-66-6 | Approved|Investigational | Target |
| DB02126 | 4-Carboxycinnamic Acid | Small Molecule | Experimental | Target | |
| DB07427 | 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine | Small Molecule | Experimental | Target | |
| DB07428 | 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine | Small Molecule | Experimental | Target | |
| DB07645 | SEBACIC ACID | Small Molecule | Experimental | Target | |
| DB08077 | 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID | Small Molecule | Experimental | Target | |
| DB08262 | 2,6-dicarboxynaphthalene | Small Molecule | 1141-38-4 | Experimental | Target |
| DB08486 | Efaproxiral | Small Molecule | 131179-95-8 | Investigational | Target |
| DB08632 | 1,3,5-BENZENETRICARBOXYLIC ACID | Small Molecule | Experimental | Target | |
| DB09112 | Nitrous acid | Small Molecule | 7782-77-6 | Approved|Investigational | Target |
| DB09130 | Copper | Small Molecule | 7440-50-8 | Approved|Investigational | Target |
| DB09140 | Oxygen | Small Molecule | 7782-44-7 | Approved | Target |
| DB09146 | Iron saccharate | Small Molecule | 8047-67-4 | Approved | Target |
| DB09147 | Ferric pyrophosphate | Small Molecule | 10058-44-3 | Experimental | Target |
| DB09517 | Sodium ferric gluconate complex | Small Molecule | 34089-81-1 | Approved | Target |
| DB13995 | Ferric pyrophosphate citrate | Small Molecule | 1802359-96-1 | Approved|Investigational | Target |
| ID | Drug Name | Action | PubMed |
|---|---|---|---|
| C036423 | 1-aminomethylphosphonic acid | [Herbicides co-treated with 1-aminomethylphosphonic acid] results in decreased expression of HBA1 mRNA | 20566314 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene results in increased expression of HBA1 mRNA" | 16917068 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of HBA1 mRNA" | 19417177 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of HBA1 mRNA" | 12376462 |
| C030370 | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | "2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of HBA1 mRNA" | 20206263 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of HBA1 mRNA | 26690555 |
| C038328 | BEP protocol | BEP protocol results in increased expression of HBA1 mRNA | 18987330 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of HBA1 mRNA | 17404688 |
| D001710 | Biotin | [Chromium co-treated with Biotin] results in decreased expression of HBA1 protein modified form | 17684468 |
| D001710 | Biotin | [chromium tripicolinate co-treated with Biotin] results in decreased expression of HBA1 protein modified form | 17684468 |
| C006780 | bisphenol A | bisphenol A results in increased expression of HBA1 mRNA | 24988533 |
| D002065 | Buspirone | Buspirone results in decreased expression of HBA1 mRNA | 24136188 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of HBA1 mRNA | 18804290 |
| C034939 | cadmium sulfide | [cadmium telluride co-treated with cadmium sulfide] results in increased expression of HBA1 mRNA | 20596552 |
| C028337 | cadmium telluride | [cadmium telluride co-treated with cadmium sulfide] results in increased expression of HBA1 mRNA | 20596552 |
| D000074262 | Canola Oil | Canola Oil metabolite results in increased expression of HBA1 mRNA | 27363782 |
| C520092 | cetilistat | cetilistat results in decreased expression of HBA1 protein modified form | 19461584 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of HBA1 mRNA | 18804290 |
| D002857 | Chromium | [Chromium co-treated with Biotin] results in decreased expression of HBA1 protein modified form | 17684468 |
| D002857 | Chromium | Chromium results in decreased glycation of HBA1 protein | 14658419 |
| C079689 | chromium tripicolinate | [chromium tripicolinate co-treated with Biotin] results in decreased expression of HBA1 protein modified form | 17684468 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in decreased expression of HBA1 mRNA | 24690739 |
| D003300 | Copper | Copper results in decreased expression of HBA1 mRNA | 25646894 |
| D003300 | Copper | Copper results in increased expression of HBA1 mRNA | 25646894 |
| C030123 | coumarin | coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | 19647726 |
| D003471 | Cuprizone | Cuprizone results in increased expression of HBA1 mRNA | 26577399 |
| C009160 | cyclonite | cyclonite results in decreased expression of HBA1 mRNA | 20965580 |
| D002945 | Cisplatin | Cisplatin results in increased expression of HBA1 mRNA | 21603599 |
| D004026 | Dieldrin | Dieldrin results in decreased expression of HBA1 protein | 20584760 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of HBA1 mRNA | 21527772 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HBA1 mRNA" | 12376462 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in decreased expression of HBA1 mRNA | 24690739 |
| D052244 | Endocrine Disruptors | Endocrine Disruptors results in increased expression of HBA1 mRNA | 25198161 |
| D005472 | Fluorouracil | TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA] | 15016801 |
| D005485 | Flutamide | Flutamide results in decreased expression of HBA1 mRNA | 24136188 |
| D005947 | Glucose | Glucose results in increased glycation of HBA1 protein | 26163454 |
| D006540 | Herbicides | [Herbicides co-treated with 1-aminomethylphosphonic acid] results in decreased expression of HBA1 mRNA | 20566314 |
| D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA | 17183730 |
| D007501 | Iron | AHSP protein binds to and affects the folding of and affects the stability of [HBA1 protein binds to Iron] | 16901899 |
| D001556 | Lindane | Lindane results in decreased expression of HBA1 mRNA | 18804290 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of HBA1 mRNA | 24136188 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in decreased expression of HBA1 mRNA | 18804290 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased methylation of HBA1 protein | 15655799 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of HBA1 mRNA | 15120970 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased carbamoylation of HBA1 protein | 15655799 |
| D009151 | Mustard Gas | Mustard Gas affects the expression of HBA1 mRNA | 15651846 |
| C051752 | nefazodone | nefazodone results in decreased expression of HBA1 mRNA | 24136188 |
| C017557 | nickel subsulfide | nickel subsulfide results in decreased expression of HBA1 mRNA | 21086188 |
| C012655 | nimesulide | nimesulide results in decreased expression of HBA1 mRNA | 24136188 |
| C055122 | orlistat | orlistat results in decreased expression of HBA1 protein modified form | 19207292|1946158 |
| D010100 | Oxygen | HBA1 protein binds to Oxygen | 1634355 |
| D010100 | Oxygen | HBA1 protein polymorphism binds to Oxygen | 1634355 |
| D052638 | Particulate Matter | HBA1 alternative form promotes the reaction [Particulate Matter results in increased expression of CD40] | 21169129 |
| D052638 | Particulate Matter | HBA1 alternative form promotes the reaction [Particulate Matter results in increased expression of CD80] | 21169129 |
| D052638 | Particulate Matter | HBA1 alternative form promotes the reaction [Particulate Matter results in increased expression of CD86] | 21169129 |
| D052638 | Particulate Matter | HBA1 alternative form promotes the reaction [Particulate Matter results in increased expression of FCER2] | 21169129 |
| D052638 | Particulate Matter | HBA1 alternative form results in increased susceptibility to Particulate Matter | 21169129 |
| C036567 | perfluorodecanoic acid | perfluorodecanoic acid results in decreased expression of HBA1 mRNA | 21984479 |
| C101816 | perfluoro-n-nonanoic acid | perfluoro-n-nonanoic acid results in decreased expression of HBA1 mRNA | 21984479 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of HBA1 mRNA | 19162173 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of HBA1 mRNA | 19162173 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of HBA1 protein | 26879310 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of HBA1 mRNA | 21984479 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of HBA1 mRNA | 18804290 |
| C030614 | picolinic acid | picolinic acid results in decreased glycation of HBA1 protein | 22944053 |
| D010936 | Plant Extracts | Plant Extracts results in decreased glycation of HBA1 protein | 12236580 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of HBA1 mRNA | 17404688 |
| D011374 | Progesterone | Progesterone results in increased expression of HBA1 mRNA | 17404688 |
| D011748 | Pyrogallol | Pyrogallol results in increased expression of HBA1 mRNA | 20362636 |
| D011794 | Quercetin | Quercetin results in decreased expression of HBA1 protein | 19207037 |
| C059514 | resveratrol | resveratrol binds to and affects the folding of HBA1 protein | 17597382 |
| C059514 | resveratrol | resveratrol results in increased expression of HBA1 mRNA | 24526417 |
| D012524 | Sarin | Sarin results in decreased expression of HBA1 protein | 28973502 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog affects the secretion of HBA1 protein | 25895662 |
| D013311 | Streptozocin | coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | 19647726 |
| D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein | 19647726 |
| D013311 | Streptozocin | Streptozocin results in increased glycation of HBA1 protein | 21139377 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of HBA1 mRNA | 16054898 |
| D014520 | Urethane | Urethane results in increased expression of HBA1 mRNA | 28818685 |
| D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA | 17183730 |
| C025643 | vinclozolin | vinclozolin results in increased expression of HBA1 mRNA | 23034163 |
| D009536 | Niacinamide | coumarin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein] | 19647726 |
| D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in increased glycosylation of HBA1 protein | 19647726 |
| D014805 | Vitamin B 12 | Vitamin B 12 affects the expression of HBA1 protein modified form | 2299304 |
| D014805 | Vitamin B 12 | Vitamin B 12 affects the glycosylation of HBA1 protein | 2299304 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of HBA1 protein | 1991440 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in increased expression of HBA1 mRNA" | 25198161 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in decreased expression of HBA1 mRNA | 27215404 |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0004601 | peroxidase activity | CONTRIBUTES_TO | IBA | 21873635 |
| GO:0004601 | peroxidase activity | contributes_to | IDA | 19740759 |
| GO:0005344 | oxygen carrier activity | - | IBA | 21873635 |
| GO:0005344 | oxygen carrier activity | - | IEA | - |
| GO:0005506 | iron ion binding | - | IEA | - |
| GO:0005515 | protein binding | - | IBA | 21873635 |
| GO:0005515 | protein binding | - | IPI | 881729 1552945 6683087 9441940 9830011 9894000 10390349 10930828 11159543 11724557 12072504 15550245 15835899 16169070 23123858 25156257 25416956 |
| GO:0019825 | oxygen binding | - | IBA | 21873635 |
| GO:0019825 | oxygen binding | - | IEA | - |
| GO:0020037 | heme binding | - | IBA | 21873635 |
| GO:0020037 | heme binding | - | IEA | - |
| GO:0031720 | haptoglobin binding | CONTRIBUTES_TO | IBA | 21873635 |
| GO:0031720 | haptoglobin binding | contributes_to | IDA | 19740759 |
| GO:0043177 | organic acid binding | - | IBA | 21873635 |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0006898 | receptor-mediated endocytosis | - | TAS | - |
| GO:0010942 | positive regulation of cell death | - | IDA | 19740759 |
| GO:0015671 | oxygen transport | - | TAS | 7518430 |
| GO:0015701 | bicarbonate transport | - | TAS | - |
| GO:0042542 | response to hydrogen peroxide | - | IDA | 19740759 |
| GO:0042744 | hydrogen peroxide catabolic process | - | IBA | 21873635 |
| GO:0042744 | hydrogen peroxide catabolic process | - | IDA | 19740759 |
| GO:0051291 | protein heterooligomerization | - | IBA | 21873635 |
| GO:0051291 | protein heterooligomerization | - | IDA | 19740759 |
| GO:0098869 | cellular oxidant detoxification | - | IEA | - |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0005576 | extracellular region | - | TAS | - |
| GO:0005615 | extracellular space | - | IDA | 21805676 |
| GO:0005829 | cytosol | - | TAS | - |
| GO:0005833 | hemoglobin complex | - | IBA | 21873635 |
| GO:0005833 | hemoglobin complex | - | IDA | 19740759 |
| GO:0005833 | hemoglobin complex | - | TAS | 7555018 |
| GO:0016020 | membrane | - | HDA | 19946888 |
| GO:0022627 | cytosolic small ribosomal subunit | - | IDA | 8706699 |
| GO:0031838 | haptoglobin-hemoglobin complex | - | IBA | 21873635 |
| GO:0031838 | haptoglobin-hemoglobin complex | - | IDA | 19740759 |
| GO:0070062 | extracellular exosome | - | HDA | 20458337 23533145 |
| GO:0071682 | endocytic vesicle lumen | - | TAS | - |
| GO:0072562 | blood microparticle | - | HDA | 22516433 |
| Reactome ID | Reactome Term | Evidence |
|---|---|---|
| R-HSA-1237044 | Erythrocytes take up carbon dioxide and release oxygen | TAS |
| R-HSA-1247673 | Erythrocytes take up oxygen and release carbon dioxide | TAS |
| R-HSA-1480926 | O2/CO2 exchange in erythrocytes | TAS |
| R-HSA-2168880 | Scavenging of heme from plasma | TAS |
| R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | TAS |
| R-HSA-382551 | Transport of small molecules | TAS |
| R-HSA-5653656 | Vesicle-mediated transport | TAS |
| PMID | Title (Year) | Author | Journal |
|---|---|---|---|
| 7044618 | Increased plasma renin activity in type 1 diabetes with microvascular disease. (1982 May) | Drury PL | Clin Endocrinol (Oxf) |
| 8910827 | Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. (1996 Oct) | Taylor GW | J Periodontol |
| 22396814 | Socioeconomic profile of diabetic patients with and without foot problems. (2010) | Nather A | Diabet Foot Ankle |
| 10580182 | Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. (2000 Jan) | Forrest KY | Atherosclerosis |
| 3391093 | Significance of high HbA1 levels in normal glucose tolerance. (1988 May) | Modan M | Diabetes Care |
| 3528745 | Smoking and insulin sensitivity in type I diabetic patients. (1986 Sep) | Helve E | Metabolism |
| 3104511 | Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. (1986 Jul-Sep) | Breddin HK | Int Angiol |
| 3471027 | Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes. (1986 Oct-Dec) | Pontiroli AE | Acta Diabetol Lat |
| 3582077 | Black West Indian and matched white diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease. (1987 Mar-Apr) | Cruickshank JK | Diabetes Care |
| 16651834 | The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. (2006) | Tamer A | Med Princ Pract |
| 9015687 | Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. (1996 Oct) | Orchard TJ | Diabetes Res Clin Pract |
| 11262670 | Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders. (2000 Dec) | Janghorbani M | Ophthalmic Epidemiol |
| 18036065 | Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. (2007 Dec) | Sellers EA | Pediatr Diabetes |
| 17467846 | Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences. (2007 Nov) | Ruppert K | Diabetes Res Clin Pract |
| 23092212 | No effect modification of serum bilirubin or coffee consumption on the association of gamma-glutamyltransferase with glycated hemoglobin in a cross-sectional study of Japanese men and women. (2012 Oct 23) | Wang Z | BMC Endocr Disord |
| 8707978 | Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. (1996 Mar) | Thorstensson H | J Clin Periodontol |
| 3119387 | Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and Rh blood groups. (1987 Jul-Aug) | Pontiroli AE | Diabete Metab |
| 7955996 | Arterial wall changes in type 2 diabetic subjects. (1994 Aug-Sep) | Geroulakos G | Diabet Med |
| 7074002 | HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes. (1982 May) | Gray RS | Br J Ophthalmol |
| 3073031 | Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. (1988 Oct) | Owens DR | Diabetes Res |
| 8219732 | Does type II diabetes predispose to retinal vein occlusion? (1993 Jul-Sep) | Dodson PM | Eur J Ophthalmol |
| 11073184 | Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. (2000 Aug) | Weng C | Diabet Med |
| 23418907 | Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study. (2014 Mar) | Sato KK | Clin Endocrinol (Oxf) |
| 2180835 | Metabolic problems after gastric surgery. (1990 Jan-Mar) | Harju E | Int Surg |
| 8088108 | Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. (1994 May) | Bott U | Diabet Med |
| 9802746 | Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. (1998 Nov) | Forsblom CM | Diabetes Care |
| 1739347 | Limited joint mobility in subjects with insulin dependent diabetes mellitus: relationship with eye and kidney complications. (1992 Jan) | Garg SK | Arch Dis Child |
| 29539790 | Severe Periodontitis and Risk for Poor Glycemic Control in Patients with Non-Insulin-Dependent Diabetes Mellitus. (1996 Oct) | Taylor GW | J Periodontol |
| 8708424 | Vascular risk factors for atherosclerotic plaque progression in carotid artery. (1995 Dec) | Delcker A | Int Angiol |
| 23347332 | A novel echocardiographic method for the detection of subclinical atherosclerosis in newly diagnosed, untreated type 2 diabetes. (2013 Jul) | Simsek H | Echocardiography |
| 7851067 | Cholesterol rich apo B containing lipoproteins and smoking are independently associated with macrovascular disease in normotensive NIDDM patients. (1994 Oct) | Dean JD | Diabet Med |
| 11276573 | Diabetes and social conditions in Estonia. A population-based study. (2001 Mar) | Vides H | Eur J Public Health |
| 6793437 | High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes. (1981 May) | Taylor KG | Diabetologia |
| 8689845 | Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. (1996 Mar) | Katsilambros NL | Diabet Med |
| 8279674 | Improved separation of acetaldehyde-induced hemoglobin. (1993 Oct) | Hazelett SE | Alcohol Clin Exp Res |
| 1852860 | The determinants of early nephropathy in insulin-dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin. (1991 Apr) | Watts GF | Q J Med |
| 9678970 | Cardio vascular morbidity in proteinuric south Indian NIDDM patients. (1998 Jan) | Viswanatham V | Diabetes Res Clin Pract |
| 1523737 | Prevalences of risk factors and angiopathy in diabetic patients in Uppsala. (1992) | Cederholm J | Ups J Med Sci |
| 11024584 | Epidemiologic study of type 2 diabetes in Taiwan. (2000 Oct) | Chang C | Diabetes Res Clin Pract |
| 3723520 | Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes. (1986 May) | Monson JP | J R Soc Med |
| 2318103 | Cigarette smoking and neuropathy in diabetic patients. (1990 Apr) | Mitchell BD | Diabetes Care |
| 8989741 | Renal findings in patients with short-term type 2 diabetes. (1996 Dec) | Keller CK | J Am Soc Nephrol |
| 3203570 | Psychosocial correlates of survival in diabetes. (1988 Jul-Aug) | Davis WK | Diabetes Care |
| 9069569 | Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. (1997 Jan) | Spallone V | Diabetes Res Clin Pract |
| 19082520 | Sulphonylureas and cancer: a case-control study. (2009 Dec) | Monami M | Acta Diabetol |
| 9507917 | Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study. (1998 Feb) | Guillausseau PJ | Diabet Med |
| 7372025 | Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus. (1980 Mar) | Graham JJ | Diabetologia |
| 1778113 | A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, U.K. (1991 Dec) | Samanta A | Diabetes Res Clin Pract |
| 7853131 | Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. (1994 Nov) | Karjalainen KM | J Periodontol |
| 2620781 | Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. (1989 Nov) | Maser RE | Diabetes |